Harvest Fund Management Co., LTD Invitae Corp Transaction History

Harvest Fund Management Co., LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $499 - $974	-34 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$26.09 - $40.4 $13,932 - $21,573	-534 Reduced 94.01%	34 $1,000
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $38,151 - $65,697	-1,154 Reduced 67.02%	568 $21,000
Q4 2020 Feb 10, 2021	SELL	$39.09 - $57.4 $28,340 - $41,615	-725 Reduced 29.63%	1,722 $71,000
Q3 2020 Nov 04, 2020	BUY	$28.43 - $44.67 $69,568 - $109,307	2,447 New	2,447 $111,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

Stay updated on Harvest Fund Management Co., LTD with notifications on news.